Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial

IMPORTANCE: Whether culture expanded mesenchymal stem cells or whole bone marrow mononuclear cells are safe and effective in chronic ischemic cardiomyopathy (ICM) remains controversial. OBJECTIVE: To demonstrate the safety of transendocardial stem cell injection with autologous mesenchymal stem cell...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Heldman, Alan W., DiFede, Darcy L., Fishman, Joel E, Zambrano, Juan P., Trachtenberg, Barry H., Karantalis, Vasileios, Mushtaq, Muzammil, Williams, Adam R., Suncion, Viky Y., McNiece, Ian K., Ghersin, Eduard, Soto, Victor, Lopera, Gustavo, Miki, Roberto, Willens, Howard, Hendel, Robert, Mitrani, Raul, Pattany, Pradip, Feigenbaum, Gary, Oskouei, Behzad, Byrnes, John, Lowery, Maureen H., Sierra, Julio, Pujol, Mariesty V, Delgado, Cindy, Gonzalez, Phillip J., Rodriguez, Jose E., Bagno, Luiza Lima, Rouy, Didier, Altman, Peter, Foo, Cheryl Wong Po, da Silva, Jose, Anderson, Erica, Schwarz, Richard, Mendizabal, Adam, Hare, Joshua M.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111133/
https://ncbi.nlm.nih.gov/pubmed/24247587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2013.282909
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares